Boehringer Ingelheim gets FDA approval for quarterable Previcox tablets

Boehringer Ingelheim said the U.S. Food and Drug Administration approved a new Quarterable Snap-Tab design for PREVICOX chewable tablets for dogs. The company said the design allows more flexible dosing and will roll out progressively through 2026 and 2027.